Milestone in Ebola Treatment Amidst Ongoing Challenges in DRC

The first patient has been enrolled in a treatment trial for the Bundibugyo Ebola outbreak in the Democratic Republic of Congo. Despite this progress, challenges such as mistrust and violence persist. The trial will evaluate MBP134 and remdesivir, with WHO ensuring drug access post-trials if effective.